Question 1

What is the projected growth trajectory for the USA Continuous Glucose Monitoring (CGM) market between 2023 and 2028?

Accepted Answer

The USA CGM market is forecast for significant expansion, with an expected Compound Annual Growth Rate (CAGR) of 19.01%. This growth is projected to increase the market value from an initial US$3.02 billion in 2021 to US$10.22 billion by 2028, driven by factors such as increasing diabetes prevalence and technological advancements.

Question 2

What are the primary technological advancements and application areas driving innovation in the USA CGM market?

Accepted Answer

Key technological advancements include automatic real-time monitoring of interstitial glucose, wireless data transmission, and the development of CGMS-based technologies as a blueprint for closed-loop bionic/artificial pancreas systems. These innovations find applications across healthcare settings like hospital ICUs, diagnostic centers, and clinics, catering to all age groups.

Question 3

Why is the United States identified as a dominant nation in the global Continuous Glucose Monitoring (CGM) market?

Accepted Answer

The United States dominates the CGM market primarily due to its population's high prevalence of diabetes and its significant capacity to adapt to new technologies. Furthermore, the report highlights that start-up businesses within the diabetes industry are actively innovating new CGM technologies in the U.S., solidifying its market leadership.

Question 4

What key market drivers are influencing the competitive landscape and adoption of CGM devices in the USA?

Accepted Answer

Major market drivers include the growing awareness of diabetes preventative care, frequent new product launches, and supportive government efforts. Additionally, the increasing convenience of continuous glucose monitoring devices for consumers and favorable reimbursement rules are significant factors contributing to adoption and market expansion.

Question 5

How does the increasing prevalence of diabetes contribute to the growth of the USA CGM market through 2028?

Accepted Answer

The increasing prevalence of both Type-1 and Type-2 diabetes is a key driver for the USA CGM market, fueled by factors like urbanization and sedentary lifestyles. This growing diabetic population, particularly those with insulin-dependent diabetes, directly translates to increased demand for continuous monitoring devices to manage blood glucose levels effectively.

Question 6

What role do insulin pumps play in the anticipated growth of the Continuous Glucose Monitoring (CGM) device market in the USA?

Accepted Answer

The usage of CGM devices is considered essential in conjunction with insulin pumps for comprehensive diabetes management. The report anticipates a direct correlation, stating that the number of CGM devices marketed will increase as more diabetic individuals adopt insulin pumps to regulate their blood sugar levels, indicating a strong synergistic relationship between these technologies.

USA Continuous Glucose Monitoring (CGM) Market - Strategic Insights and Forecasts (2023-2028)

Insightful study of the USA Continuous Glucose Monitoring market dynamics, innovation landscape, and expanding patient monitoring applications.

Market Segmentation

By Application

By End-User Industry

REPORT DETAILS

Need Assistance?